BRAIN SCIENTIFIC (BRSF) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 5 7 sessions, October 16, 2025 to May 13, 2026
- Largest daily move
- +500% close of May 13, 2026
Company Description
BRAIN SCIENTIFIC (OTC: BRSF) is classified in the medical devices industry within the Healthcare sector and carries a market capitalization of $932.0K.
BRSF has gained 500.0% so far this year. The last closing price was $0.0006.
For FY2022, BRAIN SCIENTIFIC reported revenue of $215K with net income of -$12.3M and diluted earnings per share of -$12.95. The company operates at a net profit margin of -5753.0%.
This page collects what Stock Titan holds for BRSF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
BRAIN SCIENTIFIC (BRSF) closed at $0.0006 on May 13, 2026. So far this year, the price has gained 500.0%.
BRSF Metrics & Rankings
Price returns through May 13, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
BRAIN SCIENTIFIC has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 3 with negative movement. Key topics include acquisition, partnership, management, private placement. View all BRSF news →
SEC Filings
Financial Highlights
BRAIN SCIENTIFIC generated $215K in revenue in FY2022, retaining a 25.3% gross margin, operating income reached -$9.6M (-4478.1% operating margin), and net income was -$12.3M, reflecting a -5753.0% net profit margin. Diluted earnings per share stood at -$12.95. The company generated -$5.9M in operating cash flow. With a current ratio of 0.18, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
BRSF Company Profile & Sector Positioning
BRAIN SCIENTIFIC (BRSF) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing BRSF often look at related companies in the same sector, including DYNATRONICS CORP (DYNT), CYDUCT DIAGNOSTICS INC (CYDX), ELECTROMEDICAL TECH INC (EMED), BIONOID PHARMA INC (BINP), and QHSLAB, INC (USAQ). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BRSF's relative position within its industry.